Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Respironics Reports Record Financial Results for Fiscal Year 2007 Third Quarter, Achieves 21 Percent Global Sleep Therapy Revenue Growth
Respironics Showcases Latest Technologies at Medtrade Spring; Building Upon Strong Fiscal Third Quarter Performance, Announces Acquisition of J.H. Emerson Company
Respironics to Webcast Fiscal 2007 Third Quarter Conference Call
Respironics' I-neb(R) Device Utilized in Clinical Evaluation Of Interferon Gamma in Idiopathic Pulmonary Fibrosis Patients
Respironics Receives 510(k) Clearance from FDA for BiPAP(R) autoSV(TM) Device Designed for Complicated Sleep-Disordered Breathing Patients
Respironics to Webcast Analyst Day Presentations on Thursday, February 1, 2007
Respironics Reports Record Financial Results for Fiscal Year 2007 Second Quarter, M-series CPAP Fully Launched, OptiLife(TM) Patient Mask Introduced
Respironics to Webcast Fiscal 2007 Second Quarter Conference Call
Axeda Presents Respironics with Remote Service Leadership Award
Respironics Reports Record Financial Results for Fiscal Year 2007 First Quarter, Achieves 17 Percent Global Sleep Therapy Growth
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
